Keywords: astazeneca, gains, orphan, drug, status, merrem, astrazeneca

AstaZeneca gains orphan drug status for Merrem

Article | 18 May 2000

Print This

AstraZeneca has been granted orphan drug status in the USA for anintravenous formulation of the anti-infective Merrem (meropenem) in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in